Brief: ANI Pharmaceuticals Closes $316.25 Mln Convertible Senior Notes Offering
13/08/2024 22:06
Aug 13 (Reuters) - ANI Pharmaceuticals Inc ANIP.O :
* ANI PHARMACEUTICALS, INC. CLOSES $316.25 MILLION
CONVERTIBLE
SENIOR NOTES OFFERING INCLUDING FULL EXERCISE OF INITIAL
PURCHASERS’ OPTION TO PURCHASE ADDITIONAL NOTES
Source text for Eikon: ID:nGNX9cCD3y
Further company coverage: ANIP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ANI Pharmaceuticals
See all newsBrief: Ani Pharmaceuticals Announces The Launch Of Duloxetine Delayed-Release Capsules
Brief: Ani Pharmaceuticals Announces The FDA Approval Of Everolimus Tablets For Oral Suspension
Brief: Ani Pharmaceuticals Appoints Henry Gosebruch To Board Of Directors
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla
ANI Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary